Sterling elects corporate VPs
Edward Albright to VP-corporate services with responsibility for manufacturing, engineering and management information systems; George Doherty to VP-pharmaceutical products with responsibility for drug acquisitions and divestitures; R. Kyle Greer to VP-human resources; and Raymond Hannigan to VP and area president-Sterling International. VP-Finance George Benjamin named chief financial officer.
You may also be interested in...
In this week’s podcast, Medtech Insight's managing editor Marion Webb has an update from the virtual HLTH panel discussions on telehealth and robotics. Deputy editor Reed Miller discusses trial results from Boston Scientific’s next-generation Accurate neo2 self-expanding aortic valve presented during the Transcatheter Cardiovascular Therapeutics (TCT) meeting.
The rare disease-focused firm will pay $90m up front to acquire Orphan Technologies and its Phase I/II enzyme replacement therapy for homocystinuria. Earnouts up to $427m are possible as well.